Ruminococcus gnavus in the gut: driver, contributor, or innocent bystander in steatotic liver disease?
The FEBS Journal · 2025-03 · 292 (6) · 1252-1264
DOI: 10.1111/febs.17327 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 26.11.2024. Verfasst von Vik Meadows und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, School of Arts & Sciences, Rutgers University, Newark, NJ, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fatty Liver, Eubacteriales, Dysbiosis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Common Fund, NIDDK NIH HHS.
Abstract (Originalsprache)
The human gut microbiome plays a crucial role in regulating intestinal and systemic health, impacting host immune response and metabolic function. Dysbiosis of the gut microbiome is linked to various diseases, including steatotic liver diseases. Metabolic dysfunction‐associated steatotic liver disease (MASLD), a chronic liver disease characterized by excess hepatic lipid content and impaired metabolism, is the leading cause of liver disease worldwide. Among the gut microbes, Ruminococcus gnavus ( R. gnavus ) has garnered attention for its association with inflammatory and metabolic diseases. While R. gnavus abundance correlates to liver fat accumulation, further research is needed to identify a causal role or therapeutic intervention in steatotic liver disease. This review surveys our current understanding of R. gnavus in the development and progression of steatotic liver diseases, highlighting its potential mechanisms through metabolite secretion, and emphasizes the need for comprehensive microbiome analyses and longitudinal studies to better understand R. gnavus' impact on liver health. This knowledge could pave the way for targeted interventions aimed at modulating gut microbiota to treat and prevent MASLD and its comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences, School of Arts & Sciences, Rutgers University, Newark, NJ, USA.
- Department of Pharmacology, Physiology, and Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ, USA.
ORCID-Profile: Vik Meadows, Jayson M Antonio, Ronaldo P Ferraris, Nan Gao
Förderung
- NIGMS NIH HHS
- Common Fund
- NIDDK NIH HHS
- NCCIH NIH HHS
- Presidential Fellowship was funded by Rutgers Health (internal institution award)
- National Science Foundation
Zitieren
APA
Meadows, V., Antonio, J. M., Ferraris, R. P., & Gao, N. (2025). Ruminococcus gnavus in the gut: driver, contributor, or innocent bystander in steatotic liver disease?. The FEBS Journal, 292(6), 1252-1264. https://doi.org/10.1111/febs.17327
Vancouver
Meadows V, Antonio JM, Ferraris RP, Gao N. Ruminococcus gnavus in the gut: driver, contributor, or innocent bystander in steatotic liver disease?. The FEBS Journal. 2025;292(6):1252-1264. doi:10.1111/febs.17327
BibTeX
@article{Meadows2025,
author = {Meadows, Vik and Antonio, Jayson M and Ferraris, Ronaldo P and Gao, Nan},
title = {Ruminococcus gnavus in the gut: driver, contributor, or innocent bystander in steatotic liver disease?},
journal = {The FEBS Journal},
year = {2025},
volume = {292},
number = {6},
pages = {1252--1264},
doi = {10.1111/febs.17327}
}
EUVIMED